Krystal Biotech, Inc.
NASDAQ:KRYS · NASDAQ Global Market
+$18.29 today
Vol 0.81M · Avg 0.29M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+152.36%
Period High
$348.06
Period Low
$134.94
Latest
$348.06
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
$11.42B
TG Therapeutics, Inc.
NASDAQ:TGTX
$7.88B
Metsera, Inc.
MTSR
$7.43B
Alkermes plc
NASDAQ:ALKS
$7.42B
Vaxcyte, Inc.
NASDAQ:PCVX
$7.32B
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
$7.17B
Arcellx, Inc.
ACLX
$6.73B
PTC Therapeutics, Inc.
NASDAQ:PTCT
$6.51B
Teleflex Incorporated
NYSE:TFX
$5.53B
CRISPR Therapeutics AG
NASDAQ:CRSP
$5.12B
What is the latest KRYS filing?
The latest filing shown is 4 dated Jun 5, 2026.
How many recent filings does KRYS have?
Intrinsic Alpha currently shows 20 recent filings for KRYS.
Explore More
Continue the stock analysis
Jump to another research area for this company.